CClinicalTrials.gg
Status unknownNCT02505438Updated Dec 9, 2015

Application of Deuterated Water (D2O) to Define the Etiology of Musculoskeletal Decline in Ageing and the Efficacy of Nutritional Supplementation

An interventional study of Exercise in Healthy, sponsored by University of Nottingham. Status unknown at 1 site in United Kingdom. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-12-09.

Sponsored by University of Nottingham · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Dec 2015), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Maintaining muscle mass and function is important in healthy ageing to maintain quality of life. Loss of muscle mass is major problem, as beyond the age \~50, muscle mass declines by \~1-2% a year. To prevent this loss, the investigators need to understand the mechanism regulating muscle mass as we age. In this project the investigators aim to determine these mechanisms using a new technique of heavy water ingestion, this allows measurement of multiple aspects of skeletal muscle mass metabolism e.g. protein synthesis, over long periods (6 weeks) as people go about their normal everyday activities. The investigators also aim to determine the influence of resistance exercise training on older muscle, as well as differences between men and women in muscle responses to exercise and nutrition HMB (beta-hydroxy-beta-methylbutyrate).

02

Conditions studied

  • Healthy
03

In context

Lead sponsor

University of Nottingham is the lead sponsor of 455 studies on the registry; 77 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Young (18-30y) and old (60-75y) individuals who are generally healthy and recreationally active

Exclusion criteria

Exclusion Criteria:

  • Active cardiovascular disease
  • Cerebrovascular disease including previous stroke, aneurysm (large vessel or intracranial)
  • Respiratory disease including pulmonary hypertension or Chronic obstructive pulmonary disease, Hyper/ hypo parathyroidism, hyper/ hypothyroidism,
  • Cushing's disease, diabetes
  • Active inflammatory bowel disease
  • Renal disease
  • Malignancy
  • Recent steroid treatment (within 6 mo), or hormone replacement therapy Clotting dysfunction
  • Musculoskeletal or neurological disorders
  • Any disease requiring long-term drug prescriptions, including statins
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
48 participants (estimated)

Study arms

  • Experimental
    Young Unilateral Exercise

    Young Individuals (18-30y) studied before and after 6 weeks unilateral resistance exercise training

    Behavioral: Exercise

  • Experimental
    Old Unilateral Exercise

    Old individuals (65-75y) studied before and after 6 weeks of unilateral resistance exercise training

    Behavioral: Exercise

  • Experimental
    Old Unilateral Exercise and HMB

    Old individuals (65-75y) studied before and after 6 weeks of unilateral resistance exercise training with HMB (beta-hydroxy-beta-methylbutyrate) supplementation

    Behavioral: Exercise

  • Experimental
    Old Unilateral Exercise and Omega 3

    Old individuals (65-75y) studied before and after 6 weeks of unilateral resistance exercise training with Omega 3 supplementation

    Behavioral: Exercise

Interventions

  • BehavioralExercise
06

What researchers measure

Primary outcomes

  1. Muscle Protein Synthesis

    Comparison of muscle protein synthesis between young and older individuals and in response to 6 weeks unilateral exercise training and supplementation

    Time frame: 0-6 Weeks

  2. Muscle Strength

    Maximal voluntary contractions of the quadriceps will be performed (leg extension) in the trained and untrained legs. This will be performed at baseline and repeated throughout to monitor training progression

    Time frame: 0-6 Weeks

07

Study locations

1 of 1 sites recruiting
  • Royal Derby Hospital Medical School
    Derby, DE22 3DT, United Kingdom
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 9, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02505438
Lead sponsor
University of Nottingham
Collaborators
The Dunhill Medical Trust
Responsible party
Sponsor
First posted
Jul 22, 2015
Start date
Apr 2013
Primary completion
Dec 2015 (estimated)
Last update
Dec 9, 2015

Study contacts

Ken Smith, PhD
Contact
ken.Smith@nottingham.ac.uk
Matthew Brook
Contact
mzxmb2@nottingham.ac.uk
Ken Smith, PhD
principal investigator · University of Nottingham

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion